EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Amino acid and protein Sources: 4

Branched-chain amino acids (BCAAs)

Also called: BCAAs, leucine, isoleucine and valine, branched chain amino acids

Branched-chain amino acids are leucine, isoleucine and valine. They make up about 25% of the amino acids in foods with complete proteins, mostly animal products such as meat, poultry, fish, eggs and milk.

Category
Amino acid and protein
Forms
Leucine, isoleucine and valine (BCAA supplements, oral; intravenous BCAAs are used in some clinical trials)
Strongest evidence
B Some positive trials
Reviewed
2026-10-30

Class 1 Well studied in people. A 2026 Cochrane review pooled 18 RCTs (934 adults with hepatic encephalopathy) of BCAAs versus control interventions; 10 trials tested oral BCAA supplements and 8 tested intravenous BCAAs. [2]

Fact-checked 2026-10-30 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

3 topics studied2 body areas · strongest grade B

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Branched-chain amino acids (BCAAs) does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Branched-chain amino acids (BCAAs), evidence grade and finding
Topic studiedGradeWhat the evidence shows
Muscle soreness and muscle-damage markers after strenuous exerciseBA 2024 meta-analysis of 18 RCTs in healthy active people found lower soreness 24–96 h after damaging exercise and lower creatine kinase at some time points, but no effect on lactate dehydrogenase. [3]
Endurance performance and muscle gains with trainingCODS describes a limited number of short-term trials with little evidence of better endurance performance; about 10–14 g/day might enhance training gains in muscle mass and strength, and effects on muscle protein synthesis are inconsistent. [1]
Hepatic encephalopathy in people with cirrhosisBA 2026 Cochrane review (18 RCTs, 934 adults; oral or intravenous) found BCAAs reduced hepatic encephalopathy (RR 0.79; low certainty); the effect on all-cause mortality was very uncertain. [2]

Main constituents: Leucine, isoleucine and valine; together they make up about 14%–18% of the amino acids in human skeletal muscle proteins [1]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • About 10–14 g/day of supplemental BCAAs in studies of muscle gains during training. [1]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Pregnancy and breastfeeding
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Interactions with medicines
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    None on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • ODS states that up to 20 g/day of BCAA supplements in divided doses appear to be safe; for leucine alone it cites an upper safe limit of 500 mg/kg per day in healthy young and elderly men (about 38 g/day for a 75 kg man). [1]
  • In the Cochrane review, nausea and diarrhea occurred in 12% of participants given BCAAs and 3% of controls; the evidence on this outcome is very uncertain. [2]
Regulation

Regulatory status

  • US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [4]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Leucine, isoleucine and valine (the three branched-chain amino acids) Amino acids, amines and peptides (amino acids) [P5]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • No NDI notification naming branched-chain amino acids, leucine or isoleucine was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29); one entry (NDI 335, submitted 2005-06-01) names L-valine as one component of a nine-ingredient combination. FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P1]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of branched-chain amino acids, leucine, isoleucine or valine was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P2]
  • The NTP Technical Reports index (TR-001 to TR-606) lists no study of leucine, isoleucine, valine or branched-chain amino acids (checked 2026-10-29). [P3]

Liver (NIH LiverTox)

  • No published information found in the sources checked.

Interactions with medicines

  • No published information found in the sources checked.

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; FDA may exempt a firm only by granting a petition under 111.75(a)(1)(ii). [P4]

Supply and conservation

  • No published information found in the sources checked.

Absorption in people

  • No published information found in the sources checked.

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • No published information found in the sources checked.

Sources for this profile

  1. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  2. IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1–142 (last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
  3. National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606), 2026-10-29. ntp.niehs.nih.gov
  4. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
  5. NIH Office of Dietary Supplements. Dietary Supplements for Exercise and Athletic Performance: Fact Sheet for Health Professionals (no printed update date; page last modified 2026-10-25 per page metadata), 2026-10-25. ods.od.nih.gov
Sources

Sources

  1. NIH Office of Dietary Supplements. Dietary Supplements for Exercise and Athletic Performance: Fact Sheet for Health Professionals (no printed update date captured; page last modified 2026-10-25 per page metadata), 2026-10-25. ods.od.nih.gov
  2. Aamann L, et al. Branched-chain amino acids for people with cirrhosis and hepatic encephalopathy. Cochrane Database Syst Rev 2026;1:CD001939 (PMID 41542879), 2026-01-16. pubmed.ncbi.nlm.nih.gov
  3. Salem A, et al. Attenuating muscle damage biomarkers and muscle soreness after an exercise-induced muscle damage with branched-chain amino acid (BCAA) supplementation: a systematic review and meta-analysis with meta-regression. Sports Med Open 2024;10(1):42 (PMID 38625669), 2024-04-16. pubmed.ncbi.nlm.nih.gov
  4. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in amino acid and protein: 5-HTP (5-hydroxytryptophan) · Beta-alanine · BPC-157 · Carnosine (L-carnosine) · Collagen peptides · Creatine · Glutathione · L-arginine · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.